Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health
Amedisys Inc. (AMED) disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. (UNH), and terminated its merger with Option Care Health Inc. (OPCH)agreed on in early-May. Under terms of deal with UnitedHealth, each Amedisys share will be converted into the right to receive $101 in cash, which represents as 10.7% premium to Friday's closing price of $91.21. The agreement comes after the at-home healthcare services company disclosed in early-June that it had received a $100-a-shares cash bid from UnitedHealth's Optum, which it believed would be considered "superior" to Option Care Health's all-stock bid. Amedisys said Option Care Health will receive a $106 million deal-termination fee. Based on Amedisys' 32.56 million shares outstanding as of April 28, UnitedHealth's buyout bid values Amedisys at $3.29 billion. Once the deal closes Amedisys will become a wholly-owned subsidiary of UnitedHealth. Amedisys shares gained 0.3% in premarket trading, UnitedHealth's stock edged up 0.2% and Option Care Health shares rallied 5.6%, while futures for the S&P 500 slipped 0.1%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-26-23 0909ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track